Evidence map›Paper›PMID 31665742›Full record

ArticleNucleic acids research2019

Human mitochondrial DNA is extensively methylated in a non-CpG context.

Vibha Patil, Cyrille Cuenin, Felicia Chung, Jesus R Rodriguez Aguilera, Nora Fernandez-Jimenez, Irati Romero-Garmendia, Jose Ramon Bilbao, Vincent Cahais, Joseph Rothwell, Zdenko Herceg

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 145 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Mitoepigenetic Alterations in Early-Onset Parkinson's Disease.International journal of molecular sciences · 2026
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Cytosine methylase and hydroxymethylase activity in mammalian mitochondria.Frontiers in cell and developmental biology · 2025
    Article
  20. Review

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Vibha PatilEpigenetics Group, International Agency for Research on Cancer (IARC), 69372 Lyon Cedex 08, France.
Cyrille CueninEpigenetics Group, International Agency for Research on Cancer (IARC), 69372 Lyon Cedex 08, France.
Felicia ChungEpigenetics Group, International Agency for Research on Cancer (IARC), 69372 Lyon Cedex 08, France.
Jesus R Rodriguez AguileraEpigenetics Group, International Agency for Research on Cancer (IARC), 69372 Lyon Cedex 08, France.
Nora Fernandez-JimenezDepartment of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country (UPV/EHU), Biocruces-Bizkaia Health Research Institute, Leioa, Basque Country 48940, Spain.
Irati Romero-GarmendiaDepartment of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country (UPV/EHU), Biocruces-Bizkaia Health Research Institute, Leioa, Basque Country 48940, Spain.
Jose Ramon BilbaoDepartment of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country (UPV/EHU), Biocruces-Bizkaia Health Research Institute, Leioa, Basque Country 48940, Spain.
Vincent CahaisEpigenetics Group, International Agency for Research on Cancer (IARC), 69372 Lyon Cedex 08, France.
Joseph RothwellNutritional Epidemiology Group, International Agency for Research on Cancer (IARC), 69372 Lyon Cedex 08, France.
Zdenko HercegEpigenetics Group, International Agency for Research on Cancer (IARC), 69372 Lyon Cedex 08, France.
Centre international de recherche sur le cancer · FRUniversity of the Basque Country · ES

Funding

World Health Organization 001
6 · The paper itself

Abstract

Mitochondrial dysfunction plays critical roles in cancer development and related therapeutic response; however, exact molecular mechanisms remain unclear. Recently, alongside the discovery of mitochondrial-specific DNA methyltransferases, global and site-specific methylation of the mitochondrial genome has been described. Investigation of any functional consequences however remains unclear and debated due to insufficient evidence of the quantitative degree and frequency of mitochondrial DNA (mtDNA) methylation. This study uses WGBS to provide the first quantitative report of mtDNA methylation at single base pair resolution. The data show that mitochondrial genomes are extensively methylated predominantly at non-CpG sites. Importantly, these methylation patterns display notable differences between normal and cancer cells. Furthermore, knockdown of DNA methyltransferase enzymes resulted in a marked global reduction of mtDNA methylation levels, indicating these enzymes may be associated with the establishment and/or maintenance of mtDNA methylation. DNMT3B knockdown cells displayed a comparatively pronounced global reduction in mtDNA methylation with concomitant increases in gene expression, suggesting a potential functional link between methylation and gene expression. Together these results demonstrate reproducible, non-random methylation patterns of mtDNA and challenge the notion that mtDNA is lowly methylated. This study discusses key differences in methodology that suggest future investigations must allow for techniques that assess both CpG and non-CpG methylation.

Indexed as

AnimalsCpG IslandsDNA (Cytosine-5-)-MethyltransferasesDNA MethylationDNA Methyltransferase 3BDNA, MitochondrialGene Expression RegulationHumansMitochondriaDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3BDNA, Mitochondrial

Identifiers

PMID31665742
PMCPMC6821263
OpenAlexW2971428127

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.